LIN28B and cholangiocarcinoma: This finding provides the evidence that LIN28B/IL-6/STAT3 signaling cascade may be involved in carcinogenesis of CCA and also suggests LIN28B and its downstream signaling may be an interesting therapeutic strategy for patients with CCA.